NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Cover of Pain Management and the Opioid Epidemic

Pain Management and the Opioid Epidemic

Balancing Societal and Individual Benefits and Risks of Prescription Opioid Use

Authors: ; ; ; . Editors: Jonathan K. Phillips, Morgan A. Ford, and Richard J. Bonnie.

Washington (DC): National Academies Press (US); .
ISBN-13: 978-0-309-45954-9ISBN-10: 0-309-45954-0

Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.

Contents

This activity was supported by Grant No. HHSF223201610015C from the U.S. Food and Drug Administration. Any opinions, findings, conclusions, or recommendations expressed in this publication do not necessarily reflect the views of any organization or agency that provided support for the project.

Suggested citation:

National Academies of Sciences, Engineering, and Medicine. 2017. Pain management and the opioid epidemic: Balancing societal and individual benefits and risks of prescription opioid use. Washington, DC: The National Academies Press. doi: https://doi.org/10.17226/24781.

Copyright 2017 by the National Academy of Sciences. All rights reserved.
Bookshelf ID: NBK458660PMID: 29023083DOI: 10.17226/24781

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (5.4M)

Related information

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...